Source

AtaiBeckley's 8-K filed September 11 reports the material event behind Friday's missing bar: the sale to Eli Lilly pays $6.75 in cash plus a contingent value right, and the shares did not trade on the session (Schwab shows zero volume against a $7.35 prior close). The deal was announced in mid-July and the desk's own August pull already carried the Lilly terms; the September 11 filing is the closing. A name whose bar stops because the company was bought is a corporate action, not a data fault: the desk retires it from coverage the way it retires any delisted name, and the halt reads as the deal, not as a hold. Read-through: Lilly keeps buying — the same week its own insiders were the largest captured sellers on the board.

Takeaway

AtaiBeckley's 8-K filed September 11 reports the material event behind Friday's missing bar: the sale to Eli Lilly pays $6.75 in cash plus a contingent value right, and the shares did not trade on the session (Schwab shows zero volume against a $7.35 prior close). The deal was announced in mid-July and the desk's own August pull already carried the Lilly terms; the September 11 filing is the closing. A name whose bar stops because the company was bought is a corporate action, not a data fault: the desk retires it from coverage the way it retires any delisted name, and the halt reads as the deal, not as a hold. Read-through: Lilly keeps buying — the same week its own insiders were the largest captured sellers on the board.